With only 3 months to go before the 7th edition of Farmaforum takes place, we already know an advance of its program of conferences, lectures and round tables. Thus, throughout April 15 and 16, topics such as the evolution of the pharmaceutical market, biosimilars and advanced therapies as a factor of change and innovation in the sector, quality management in international CMOs, trade in APIs or the medical use of cannabis will be addressed.

After the official opening Concha Almarza, general manager, Spain & Portugal of Iqvia, will review the evolution of the pharmaceutical market. Then Eduado Sanz, CEO of Pharmaplan, founding partner of Farmaforum Formación and director of the Farmaforum congress, will moderate a round table on sterile zone operations with representatives from ISPE Spain, Labiana, Klinea and Novartis. And to close the morning, Eduardo Sanz himself will give a talk entitled Pharma strategic hand book.

The afternoon of April 15 will begin with a presentation by ISPE Spain, followed by a speech by Alfonso Camba, general manager of Mundipharma Biologics, on biosimilars. Finally, the first day will close with a round table discussion on the paradigm shift represented by advanced therapies. In this case Andrea Romero, Imereti’s quality manager, will be the moderator and representatives from Imereti, Fundación Jiménez Díaz, Agencia Española del Medicamento y Productos Sanitarios, SERMES CRO and Gilead Madrid will intervene.

On April 16, the congress Farmaforum opens with the quality management in the international CMOs in charge of Julio C. Arce de la Plaza, corporate director Quality Rovi. Then Enric Castell, Airpharm operations director, will analyze the management of international drug transport and Pau Franquet, CEO/founder of Kemiex AG, will talk about the digitalization of API trade.